Nifty

:

16910.30

Sensex

:

57572.08

-41.40 (-0.24%)
-41.64 (-0.07%)

Login

Nifty
Sensex

:
:

16910.30
57572.08

-41.40 (-0.24%)
-41.64 (-0.07%)

Sun Pharma Advanced Research Company Ltd.

Pharmaceuticals & Drugs - Global

Rating :

40/99

BSE: 532872 | NSE: SPARC

Watchlist

NSE BSE

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,812.18
N/A
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,885.96
N/A
-23.02

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

4.63
11.89
21.35

EBITDA CAGR (%)

10 Years
5 Years
3 Years

27.26
-5.10
-9.64

PAT CAGR (%)

10 Years
5 Years
3 Years

24.63
0.64
-13.33

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-18.88
-18.88
-21.12

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-33.21
-31.04
-31.80

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var%
Net Sales 131.09 62.15 110.93% 31.54 27.87 13.17% 28.46 21.99 29.42% 25.24 28.06 -10.05%
Expenses 114.91 73.42 56.51% 94.14 82.54 14.05% 106.66 76.26 39.86% 91.78 78.49 16.93%
EBITDA 16.18 -11.27 - -62.60 -54.67 - -78.20 -54.27 - -66.54 -50.43 -
EBIDTM 12.34% -18.13% -198.48% -196.16% -274.77% -246.79% -263.63% -179.72%
Other Income 0.03 0.34 -91.18% 0.06 5.48 -98.91% 0.18 0.80 -77.50% 0.22 0.33 -33.33%
Interest 2.93 2.33 25.75% 2.86 3.41 -16.13% 1.63 5.37 -69.65% 2.22 4.02 -44.78%
Depreciation 3.13 2.58 21.32% 3.00 2.54 18.11% 2.70 2.53 6.72% 2.51 2.60 -3.46%
PBT 10.15 -15.84 - -68.40 -55.14 - -82.35 -61.37 - -71.05 -56.72 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 10.15 -15.84 - -68.40 -55.14 - -82.35 -61.37 - -71.05 -56.72 -
PATM 7.74% -25.49% -216.87% -197.85% -289.35% -279.08% -281.50% -202.14%
EPS 0.37 -0.58 - -2.48 -2.00 - -2.99 -2.23 - -2.58 -2.06 -

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 216.33 137.25 252.96 76.81 182.87 78.26 181.02 161.28 155.74 167.03 87.28 Net Sales Growth 54.44% -45.74% 229.33% -58.00% 133.67% -56.77% 12.24% 3.56% -6.76% 91.37% Cost Of Goods Sold 22.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 193.62 137.25 252.96 76.81 182.87 78.26 181.02 161.28 155.74 167.03 87.28 GP Margin 89.50% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure 407.49 324.00 387.93 386.83 334.16 320.87 303.72 224.48 190.83 133.54 104.04 Power & Fuel Cost - 4.62 4.60 5.14 5.08 4.92 4.67 4.49 4.78 3.95 3.85 % Of Sales - 3.37% 1.82% 6.69% 2.78% 6.29% 2.58% 2.78% 3.07% 2.36% 4.41% Employee Cost - 96.78 91.59 93.09 81.06 100.92 84.30 56.60 45.79 40.40 36.55 % Of Sales - 70.51% 36.21% 121.20% 44.33% 128.95% 46.57% 35.09% 29.40% 24.19% 41.88% Manufacturing Exp. - 134.27 209.78 30.47 17.81 31.79 29.39 26.42 17.96 16.19 15.84 % Of Sales - 97.83% 82.93% 39.67% 9.74% 40.62% 16.24% 16.38% 11.53% 9.69% 18.15% General & Admin Exp. - 85.92 78.49 251.32 221.40 181.18 180.29 131.88 119.37 71.71 46.26 % Of Sales - 62.60% 31.03% 327.20% 121.07% 231.51% 99.60% 81.77% 76.65% 42.93% 53.00% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 2.41 3.48 6.81 8.80 2.05 5.06 5.08 2.94 1.29 0.00 % Of Sales - 1.76% 1.38% 8.87% 4.81% 2.62% 2.80% 3.15% 1.89% 0.77% 1.76% EBITDA -191.16 -186.75 -134.97 -310.02 -151.29 -242.61 -122.70 -63.20 -35.09 33.49 -16.76 EBITDA Margin -88.36% -136.07% -53.36% -403.62% -82.73% -310.01% -67.78% -39.19% -22.53% 20.05% -19.20% Other Income 0.49 6.84 5.41 9.76 13.51 4.94 13.72 2.94 3.03 10.00 1.62 Interest 9.64 13.33 10.65 2.67 0.09 0.12 1.82 2.16 0.22 5.60 3.95 Depreciation 11.34 10.16 10.92 9.48 7.55 8.18 8.24 7.58 7.24 3.57 3.40 PBT -211.65 -203.40 -151.14 -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 34.32 -22.49 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.00 0.00 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.66% 0.00% PAT -211.65 -203.40 -151.14 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 30.32 -22.49 PAT before Minority Interest -211.65 -203.40 -151.14 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 30.32 -22.49 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -97.84% -148.20% -59.75% -406.72% -79.53% -251.73% -65.76% -43.40% -25.38% 18.15% -25.77% PAT Growth 0.00% - - - - - - - - - EPS -7.69 -7.39 -5.49 -11.35 -5.28 -7.16 -4.32 -2.54 -1.44 1.10 -0.82

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 31.23 -168.25 -18.64 296.24 184.72 158.16 31.80 99.80 139.30 108.43 Share Capital 27.19 26.21 26.21 26.21 25.09 24.69 23.67 23.67 23.67 23.66 Total Reserves -230.22 -194.46 -44.84 270.03 67.96 133.47 6.23 76.13 115.63 84.77 Non-Current Liabilities 77.43 164.59 55.85 7.20 11.98 10.36 10.02 9.72 9.45 6.32 Secured Loans 0.00 112.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 6.38 1.09 1.64 2.18 2.73 3.27 3.82 4.36 Long Term Provisions 8.15 8.63 10.23 6.11 10.34 8.18 7.30 6.37 5.48 1.73 Current Liabilities 171.43 233.35 235.36 95.04 116.11 108.03 124.84 37.15 38.79 94.24 Trade Payables 72.19 91.17 158.84 82.92 102.48 94.45 58.15 27.01 29.75 12.79 Other Current Liabilities 93.96 56.44 11.20 7.66 9.42 9.81 12.09 8.98 7.58 3.79 Short Term Borrowings 0.00 80.00 60.00 0.00 0.10 0.41 52.48 0.40 0.82 75.97 Short Term Provisions 5.28 5.75 5.31 4.46 4.10 3.35 2.12 0.77 0.64 1.69 Total Liabilities 280.09 229.69 272.57 398.48 312.81 276.55 166.66 146.67 187.54 208.99 Net Block 91.87 90.56 103.86 57.56 51.74 69.16 69.96 66.79 64.49 65.55 Gross Block 133.15 122.51 135.50 80.22 67.17 77.28 106.82 96.38 86.98 84.57 Accumulated Depreciation 41.28 31.95 31.64 22.66 15.44 8.12 36.86 29.58 22.49 19.02 Non Current Assets 208.93 166.58 205.38 141.09 137.59 118.27 98.88 83.46 76.87 69.14 Capital Work in Progress 26.37 5.23 32.07 24.13 3.27 1.47 0.87 0.02 0.76 0.16 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 67.83 70.64 69.24 59.29 82.48 47.45 27.99 16.55 11.50 3.30 Other Non Current Assets 22.87 0.15 0.20 0.12 0.10 0.19 0.07 0.09 0.11 0.13 Current Assets 71.15 63.11 67.19 257.38 175.22 158.28 66.59 62.93 110.12 139.01 Current Investments 11.66 6.43 8.49 210.58 107.57 9.65 0.00 0.00 6.50 96.91 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 27.74 17.58 16.05 10.17 17.56 38.90 9.16 19.89 28.00 25.06 Cash & Bank 1.23 9.31 0.46 0.68 1.32 70.31 12.75 17.34 6.56 6.72 Other Current Assets 30.52 8.10 2.86 2.57 48.77 39.43 44.69 25.70 69.06 10.33 Short Term Loans & Adv. 28.02 21.70 39.33 33.39 46.73 37.48 43.35 24.27 63.34 9.69 Net Current Assets -100.28 -170.24 -168.17 162.34 59.11 50.25 -58.24 25.79 71.33 44.77 Total Assets 280.08 229.69 272.57 398.47 312.81 276.55 166.65 146.67 187.55 208.99

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity -208.23 -151.90 -210.81 -171.91 -182.77 -128.04 -44.21 -41.17 36.90 -95.34 PBT -203.40 -151.14 -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 34.32 -22.49 Adjustment 16.67 48.75 9.44 -21.77 3.82 -1.14 9.25 4.73 0.90 5.71 Changes in Working Capital -26.05 -47.88 102.02 -0.17 20.48 12.86 30.41 -3.74 9.80 -77.91 Cash after chg. in Working capital -212.78 -150.26 -200.95 -167.38 -221.68 -107.32 -30.34 -38.53 45.03 -94.69 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 4.54 -1.63 -9.86 -4.54 -10.08 -20.72 -13.87 -2.64 -8.13 -0.65 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 48.98 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -29.17 1.56 155.35 -102.19 -104.62 -6.61 -13.08 53.00 43.59 -99.31 Net Fixed Assets -31.78 39.83 -63.22 -33.91 8.31 28.94 -11.29 -8.66 -3.01 -4.01 Net Investments -5.23 2.06 202.09 -103.01 -97.92 -9.65 0.00 6.50 90.41 -96.91 Others 7.84 -40.33 16.48 34.73 -15.01 -25.90 -1.79 55.16 -43.81 1.61 Cash from Financing Activity 229.32 159.28 55.46 274.25 224.01 194.25 50.55 -1.26 -80.84 194.38 Net Cash Inflow / Outflow -8.08 8.95 0.00 0.15 -63.38 59.60 -6.74 10.57 -0.35 -0.27 Opening Cash & Equivalents 9.30 0.35 0.35 0.20 63.58 4.00 10.63 0.01 0.33 0.57 Closing Cash & Equivalent 1.22 9.30 0.35 0.35 0.20 63.58 4.00 10.63 0.01 0.33

Financial Ratios

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) -7.47 -6.42 -0.71 11.30 3.71 6.41 1.21 4.18 5.82 4.52 ROA -79.80% -60.18% -93.11% -40.89% -66.85% -53.72% -44.68% -23.65% 15.29% -15.27% ROE 0.00% 0.00% -225.08% -74.72% -156.84% -127.40% -109.16% -33.17% 24.62% -110.94% ROCE -225.57% -254.10% -178.95% -59.95% -113.05% -94.66% -71.37% -31.74% 24.02% -19.55% Fixed Asset Turnover 1.07 1.96 0.71 2.48 1.08 1.97 1.59 1.70 1.95 1.06 Receivable days 60.25 24.26 62.28 27.67 131.66 48.45 32.87 56.11 57.97 61.31 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 0.00 0.00 316.55 300.15 244.72 218.01 163.03 136.14 120.80 88.65 Cash Conversion Cycle 60.25 24.26 -254.27 -272.48 -113.05 -169.56 -130.16 -80.03 -62.83 -27.34 Total Debt/Equity -0.37 -1.37 -3.59 0.01 0.02 0.02 1.94 0.04 0.04 0.75 Interest Cover -14.26 -13.19 -115.79 -1547.78 -1596.71 -64.41 -31.45 -180.04 7.13 -4.69

Top Investors:

sun pharmaceutical industries key employees benefit trust

lakshdeep investments & finance (p) ltd

vijay mohanlal parekh

paresh mohanlal parekh

Annual Reports:

News Update:

Sun Pharma Adv. Res - Quarterly Results
13th Feb 2023, 14:28 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback